Angiogenesis and arthritis

Rheumatology

Volumn 38, Issue 2, 1999, Pages 103-112

  Walsh, D A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Angiogenesis; Apoptosis; Cell proliferation; Hypoxia; Ossification; Osteoarthritis; Rheumatoid arthritis; Synovitis; Wound healing

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; FUMAGILLOL CHLOROACETYLCARBAMATE; GOLD; INTEGRIN ALPHA V BETA 3 ANTAGONIST; METALLOPROTEINASE INHIBITOR; METHOTREXATE; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE; THALIDOMIDE; THROMBOSPONDIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTHRITIS; BONE DESTRUCTION; CARTILAGE DEGENERATION; CELL PROLIFERATION; DEVELOPMENT; DRUG TARGETING; FEMALE INFERTILITY; FRACTURE; GASTROINTESTINAL DISEASE; HUMAN; HYPOXEMIA; INFLAMMATION; MUSCLE DISEASE; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOPHYTE; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REPRODUCTION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS; TERATOGENICITY; TISSUE REPAIR; TOPICAL DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ARTHRITIS; FEMALE; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0032703283     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.2.103     Document Type: Review

References (144)

1. Folkman J, Brem H. Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R. eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1992:821-39.
2. Colville-Nash PR, Scott DL. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 1992;51:919-25.
3. Anderson ND, Anderson AO, Wyllie RG. Microvascular changes in lymph nodes draining skin allografts. Am J Pathol 1975;81:131-60.
4. Désmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
5. Walsh DA, Hu D-E, Mapp PI, Polak JM, Blake DR, Fan T-PD. Substance P and new vessel formation in the rat subcutaneous sponge granuloma. Histochem J 1996;28:759-69.
6. Walsh DA, Hu D-E, Wharton J, Catravas JD, Blake DR, Fan T-PD. Sequential development of angiotensin receptors and angiotensin converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br J Pharmacol 1997;120:1302-11.
7. Walsh DA, Fan T-PD. Bradykinin as a growth factor. In: Farmer SG ed. The handbook of immunopharmacology; the kinin system. London: Academic Press, 1997:301-14.
8. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 1990;40:264-78.
9. Mapp PI, Kidd BL, Gibson SJ et al. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990;37:143-53.
10. Hægerstrand A, Dalsgaard C-J, Jonzon B, Larsson O, Nilsson J. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990;87:3299-303.
11. Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR. Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 1993;142:1610-21.
12. Ben Ezra D. Vasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol 1978;86:455-61.
13. 2 and angiogenesis. Proc Soc Exp Biol Med 1983;72:214-8.
14. Ziche M, Morbidelli L, Masini E et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994;94:2036-44.
15. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
16. Thompson WD, Brown FI. Quantitation of histamine-induced angiogenesis in the chick chorioallantoic membrane: mode of action of histamine is indirect. Int J Microcirc Clin Exp 1987;6:343-57.
17. Frewin DB, Cleland LG, Jonsson JR, Robertson PW. Histamine levels in human synovial fluid. J Rheumatol 1986;13:13-4.
18. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-8.
19. Koch AE, Harlow LA, Haines GK et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56.
20. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984;223:1296-8.
21. Qu Z, Huang XN, Ahmadi P et al. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995;73:339-46.
22. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41.
23. Koch AE, Halloran MM, Hosaka S et al. Hepatocyte growth factor: a cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum 1996; 39:1566-75.
24. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 1986;232:1250-3.
25. Shiozawa S, Shiozawa K, Tanaka Y et al. Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritis. Ann Rheum Dis 1989;48:820-8.
26. Prendergast RA, Lutty GA, Dinarello CA. Interleukin-1 induces corneal neovascularisation. Fed Proc 1987; 46:1200.
27. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M. Interleukin-1 and tumor necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 1988;73:449-53.
28. Koch AE, Polverini PJ, Kunkel SL et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-801.
29. Fett WJ, Strydom DJ, Lobb RR et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24:5480-6.
30. Hosaka S, Shah MR, Barquin N, Haines GK, Koch AE. Expression of basic fibroblast growth factor and angiogenin in arthritis. Pathobiology 1995;63:249-56.
31. Roberts AB, Sporn MB, Assoian RK et al. Transforming growth factor type beta: rapid induction of fibrosis, and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
32. Taketazu F, Kato M, Gobl A et al. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest 1994;70:620-30.
33. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-2.
34. Husby G, Williams RC. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1988;1:363-71.
35. Moghaddam A, Zhang H-T, Fan T-PD et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995;92:998-1002.
36. Takeuchi M, Otsuka T, Matsui N et al. Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid synovium. Arthritis Rheum 1994;37:662-72.
37. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324-6.
38. Henderson EB, Grootveld M, Farrell A, Smith EC, Thompson PW, Blake DR. A pathological role for damaged hyaluronan in synovitis. Ann Rheum Dis 1991;50:196-200.
39. DiPietro LA. Thrombospondin as a regulator of angiogenesis. In: Goldberg ID, Rosen EM, eds. Regulation of angiogenesis. Basel: Birkhäuser Verlag, 1997:295-314.
40. Koch AE, Friedman J, Burrows JC, Haines GK, Bouck NP. Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiology 1993;61:1-6.
41. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987;47:5155-61.
42. Dolhain RJEM, Ter Haar NT, Hoefakker S et al. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis. Br J Rheumatol 1996;35:24-32.
43. Pepper MS, Ferrara N, Orci L, Montesano R. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 1995;108:73-83.
44. Lotz M, Moats T, Villiger PM. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 1992;90:888-96.
45. Takigawa M, Nishida Y, Suzuki F et al. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 1990;171:1264-71.
46. Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol Mol Pathol 1990;59:305-12.
47. Nawrocki B, Polette M, Clavel C et al. Expression of stromelysin 3 and tissue inhibitors of matrix metalloproteinases. TIMP-1 and TIMP-2, in rheumatoid arthritis. Pathol Res Practice 1994;190:690-6.
48. Friling R, Yassur Y, Levy R et al. A role of transforming growth factor-beta 1 in the control of corneal neovascularization. In Vivo 1996;10:59-64.
49. Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. Dual role of tumor necrosis factor-α in angiogenesis. Am J Pathol 1992;140:539-44.
50. West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989;183:179-96.
51. Davis S, Aldrich TH, Jones PF et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-9.
52. Maisonpierre PC, Suri C, Jones PF et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
53. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. Mechanisms of neovascularization: vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 1984;51:624-34.
54. Roivainen A, Soderstrom KO, Pirila L et al. Oncoprotein expression in human synovial tissue: an immunohistochemical study of different types of arthritis. Br J Rheumatol 1996;35:933-42.
55. Lalor PA, Mapp PI, Hall PA, Revell PA. Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 1987; 7:183-6.
56. Wells AF, Klareskog L, Lindblad S, Laurent TC. Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: A role for macrophage-derived factors. Arthritis Rheum 1992;35:391-6.
57. Qu Z, Hernandez Garcia C, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT. Local proliferation of synoviocytes contributes to synovial hyperplasia. Arthritis Rheum 1994;37:212-20.
58. Nagashima M, Yoshino S, Ishiwata T, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995;22:1624-30.
59. Walsh DA, Wade M, Mapp PI, Blake DR. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998;152:691-702.
60. Ceponis A, Konttinen YT, Imai S et al. Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol 1998;37:170-8.
61. Graham RC, Shannon SL. Peroxidase arthritis. II. Lymphoid cell-endothelial interactions during a developing immunologic inflammatory response. Am J Pathol 1972;69:7-24.
62. Mohr W, Beneke G, Mohing W. Proliferation of synovial lining cells and fibroblasts. Ann Rheum Dis 1975;34:219-24.
63. Henderson B, Glynn LE, Bitensky L, Chayen J. Cell division in experimental allergic arthritis: proliferation of cells during the development of chronic arthritis. Ann Rheum Dis 1982;41:275-81.
64. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-84.
65. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991; 64:313-20.
66. 3 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157-64.
67. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517-9.
68. Shai SY, Fishel RS, Martin BM, Berk BC, Bernstein KE. Bovine angiotensin converting enzyme cDNA cloning and regulation. Increased expression during endothelial cell growth arrest. Circ Res 1992;70:1274-81.
69. Walsh DA, Salmon M, Mapp PI et al. Microvascular substance P binding to normal and inflamed rat and human synovium. J Pharmacol Exp Ther 1993;267:951-60.
70. Stevens CR, Blake DR, Merry P, Revell PA, Levick JR. Comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 1991;34:1508-13.
71. Ceponis A, Konttinen Y, Mackevicius Z et al. Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. J Rheumatol 1996;23:1880-6.
72. Knight AD, Levick JR. The density and distribution of capillaries around the synovial cavity. Q J Exp Physiol 1983;68:629-44.
73. FitzGerald O, Soden M, Yanni G, Robinson R, Bresnihan B. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:792-6.
74. Ellis GA, Williams RB, Edmonds SE, Blake DR. Novel technique to measure oxygen partial pressure in the rheumatoid knee. Br J Rheumatol 1992;31(suppl. 2):18.
75. Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett 1993;317:135-8.
76. Hunter W. On the structure and diseases of articulating cartilage. Philos Trans R Soc London [Biol] 1743;42:514.
77. Langer R, Brem H, Flaterman K et al. Isolation of a cartilage factor that inhibits tumor neo-vascularization. Science 1976;193:70-2.
78. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990;248:1408-10.
79. Stephens RW, Ghosh P, Taylor TK. The pathogenesis of osteoarthrosis. Med Hypoth 1979;5:809-16.
80. Bromley M, Bertfield H, Evanson JM, Woolley DE. Bidirectional erosion of cartilage in the rheumatoid knee joint. Ann Rheum Dis 1985;44:676-81.
81. Moskowitz RW, Goldberg VM. Osteophyte evolution: studies in an experimental partial meniscectomy model. J Rheumatol 1987;14(spec. no.):116-8.
82. Kauppila LI. Ingrowth of blood vessels in disc degeneration: angiographic and histological studies of cadaveric spines. J Bone Joint Surg 1995;77A:26-31.
83. Ashton IK, Roberts S, Jaffray DC, Polak JM, Eisenstein SM. Neuropeptides in the human intervertebral disc. J Orthop Res 1994;12:186-92.
84. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997;11:457-65.
85. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
86. Fox SB, Turner GD, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3, E-and P-selectins on breast cancer endothelium. J Pathol 1995;177:369-76.
87. Kraling BM, Razon MJ, Boon LM et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 1996;148:1181-91.
88. Dvorak HF, Orenstein NS, Carvalho AC et al. Induction of fibrin-gel investment: an early event in line 10 heptocarcinoma growth mediated by tumor-secreted products. J Immunol 1979;122:166-74.
89. Stout AJ, Gresser I, Thompson WD. Inhibition of wound healing in mice by local interferon alpha/beta injection, Int J Exp Pathol 1993;74:79-85.
90. Hudson N, Balsitis M, Everitt S, Hawkey CJ. Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs. Gut 1995;37:191-4.
91. Uhl E, Barker JH, Bondar I et al. Basic fibroblast growth factor accelerates wound healing in chronically ischacmic tissue. Br J Surg 1993;80:977-80.
92. Folkman J, Szabo S, Stovroff M, McNeil P, Li W, Shing Y. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy which accelerates healing. Ann Surg 1991;214:414-27.
93. Kjartansson J, Dalsgaard C-J, Jonsson CE. Decreased survival of experimental critical flaps in rats after sensory denervation with capsaicin. Plastic Reconstruct Surg 1987;79:218-21.
94. Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: degradation by migrating endothelial cells. Science 1983;221:281-3.
95. Harris ED Jr. Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis. Arthritis Rheum 1976;19:68-72.
96. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1995;1:149-53.
97. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996;76:839-85.
98. Lund-Oleson K. Oxygen tensions in synovial fluids. Arthritis Rheum 1970;13:769-76.
99. Gaffney K, Williams RB, Jolliffe VA, Blake DR. Intraarticular pressure changes in rheumatoid and normal peripheral joints. Ann Rheum Dis 1995;54:670-3.
100. 2 activity is not involved in the tumor necrosis factor-triggered apoptotic DNA fragmentation in bovine aortic endothelial cells. Biochem Biophys Res Commun 1992;188:1312-7.
101. Yang JJ, Kettritz R, Falk RJ, Jennette JC, Gaido ML. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol 1996;149:1617-26.
102. Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D. Induction of human endothelial cell apoptosis requires both heat shock and oxidative stress responses. Am J Physiol 1997;272:C1543-51.
103. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997;81:970-6.
104. Lindner H, Holler E, Ertl B et al. Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood 1997;89:1931-8.
105. Hudlicka OM, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992;72:369-417.
106. Skawina A, Litwin JA, Gorczyca J, Miodonski AJ. Blood vessels in epiphyseal cartilage of human fetal femoral bone: a scanning electron microscopic study of corrosion casts. Anat Embryol 1994;189:457-62.
107. Alini M, Marriott A, Chen T, Abe S, Poole AR. A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol 1996;176:124-32.
108. Carlevaro MF, Albini A, Ribatti D et al. Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol 1997;136:1375-84.
109. 1 in osteoblasts. J Clin Invest 1994;93:2490-6.
110. Leunig M, Yuan F, Gerweck LE, Jain RK. Effect of basic fibroblast growth factor on angiogenesis and growth of isografted bone: quantitative in vitro-in vivo analysis in mice. Int J Microcirc Clin Exp 1997;17:1-9.
111. Mori S, Yoshikawa H, Hashimoto J et al. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogcnetic protein-2. Bone 1998;22:99-105.
112. Brown RA, Weiss JB. Neovascularisation and its role in the osteoarthritic process. Ann Rheum Dis 1988;47:881-5.
113. Jones PB, Makki RJ, Weiss JB. Endothelial cell stimulating angiogenesis factor - a new biological marker. for disease activity in ankylosing spondylitis? Br J Rheumatol 1994;33:332-5.
114. Nakamura H, Yoshino S, Ishiuchi N, Yokoyama M, Hiraishi K. Angiogenesis and angiogenic growth factors in the synovium in early rheumatoid arthritis. Arthritis Rheum 1996;39:S196.
115. Walsh DA, Rodway HA, Claxson A. Vascular turnover during carrageenan synovitis in the rat. Lab Invest 78:1513-21.
116. Peacock DJ, Banquerigo ML, Brahn E. Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 1992;175:1135-8.
117. Peacock DJ, Banquerigo ML, Brahn E. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol 1995;160:178-84.
118. 3 antagonist ameliorates early and chronic arthritis. Arthritis Rheum 1997;40:S97.
119. Koch AE, Szekanecz Z, Friedman J, Haines GK, Langman CB, Bouck NP. Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis. Clin Immunol Immunopathol 1998;86:199-208.
120. Schmassmann A, Tarnawski A, Peskar BM, Varga L, Flogerzi B, Halter F. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol 1995;268:G276-85.
121. Klauber N, Rohan RM, Flynn E, D'Amato RJ. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nature Med 1997;4:443-6.
122. Fong G-H, Rassant J, Gertenstein M, Breitman M. Role of FLT-1 receptor tyrosine kinase in regulation of assembly of vascular endothelium. Nature 1995;376:6670.
123. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995;376:62-6.
124. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42.
125. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994;91:4082-5.
126. Matsubara T, Ziff M. Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest 1987;79:1440-6.
127. Matsubara T, Saura R, Hirohata K, Ziff M. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest 1989;83:158-67.
128. Hirata S, Matsubara T, Saura R, Tateishi H, Hirohata K. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum 1989;32:1065-73.
129. Madhok R, Wijelath E, Smith J, Watson J, Sturrock RD, Capell HA. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization. J Rheumatol 1991;18:199-202.
130. Saura R, Matsubara T, Mizuno K. Inhibition of neovascularization in vivo by gold compounds. Rheumatol Int 1994;14:1-7.
131. Potvin F, Petitclerc E, Marceau F, Poubelle PE. Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells. J Immunol 1997;158:1872-9.
132. Cawston T. Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target? Ann Rheum Dis 1993;52:769-70.
133. Paleolog E. Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis. Mol Pathol 1997;50:225 33.
134. Berger AE, Dortch KA, Staite ND, Mitchell MA, Evans BR, Holm MS. Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470. Agents Actions 1993;39:C86-8.
135. Sasaki A, Alcalde RE, Nishiyama A et al. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Cancer Res 1998;58:462-7.
136. v integrins. Science 1995; 270:1500-2.
137. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996;270:H411-5.
138. 1 or interleukin-1 receptor antagonists. Br J Pharmacol 1993;110:43-9.
139. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett 1993;153:37-40.
140. 3 for angiogenesis. Science 1994; 264:569-71.
141. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995;1:1024-8.
142. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998;338:1174-80.
143. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K. Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 1994;106:1106-11.
144. Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97:1114-23.